| Vol. 11.23 – 16 June, 2022 |
| |
|
|
| Scientists showed that Prevotella melaninogenica enhanced protection against Streptococcus pneumoniae, resulting in rapid pathogen clearance from the lung and improved survival in a mouse lung co-infection model. [Nature Communications] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Cell compatibility, uptake, and intracellular trafficking were characterized in the murine alveolar macrophage cell line MH-S and the human bronchial epithelial cell line BEAS-2B in vitro. [Small] |
|
|
|
| Investigators identified that signal transducer and activators of transduction 6 (STAT6) acted as a critical regulator of epithelium ferroptosis during acute lung injury. [Cell Death & Disease] |
|
|
|
| Researchers generated lung bud organoids derived from human embryonic stem cells to study the interaction of Streptococcus pneumoniae with the alveolar epithelium. [Microbiology Spectrum] |
|
|
|
| To examine the overall effect of STC1 on metabolism, scientists conducted a comprehensive metabolomics analysis to screen the overall metabolic changes induced by STC1 in an alveolar epithelial cell line. [American Journal of Respiratory Cell and Molecular Biology] |
|
|
|
| Using Sendai virus to model natural infection in mice, investigators found evidence that alveolar type 1 cells had an intermediary role by persisting in areas depleted of alveolar type 2 cells, upregulating interferon responsive genes, and receding from invading airway cells. [American Journal of Respiratory Cell and Molecular Biology] |
|
|
|
| Researchers evaluated the pharmacological activity of the ethanol extract of Veronica persica in an airway inflammation model. [Biomedicine & Pharmacotherapy] |
|
|
|
| The authors investigated the mechanisms underlying the action of interleukin-6 neutralizing antibodies in attenuating airway mucus hypersecretion in COPD. [Biomedicine & Pharmacotherapy] |
|
|
|
| Investigators assessed for changes in abundance and distribution of hemidesmosome-associated proteins following diacetyl (DA) exposure that contributed to DA-induced epithelial toxicity. [Scientific Reports] |
| |
|
|
| In an unbiased functional genetic screen for radiosensitization targets in lung cancer, scientists identified syntaxin 18, a protein involved in retrograde vesicular transport between the Golgi apparatus and endoplasmic reticulum, as mediator of radioresistance. [Cell Death & Disease] |
|
|
|
| Researchers reported monolayer cancer cell models wherein the human NSCLC cell line H2228 and pancreatic cancer cell line AsPC-1 could be reversibly induced to a quiescent state under hypoxic and serum-starved conditions. [Scientific Reports] |
|
|
|
| Scientists identified unique metabolite-related gene signatures specific for lung adenocarcinoma and lung squamous cell carcinoma and key pathways aberrantly regulated at both transcriptional and metabolic levels. [Cancer Medicine] |
|
|
|
| The functions of semaphorin 4B in lung adenocarcinoma cells were investigated by in vitro experiments, including CCK-8 and plate clone formation. [BMC Cancer] |
|
|
|
|
| Investigators discuss changes in cell populations and gene expression, highlighting potential common features, such as alveolar cell epithelial injury and aberrant repair and monocyte-derived macrophage populations. [Human Genomics] |
|
|
|
|
| Galecto, Inc. announced that the first patient has been enrolled in the Phase IIa GALLANT-1 trial. GALLANT-1 was designed to study the combination of GB1211, Galecto’s oral small molecule galectin-3 inhibitor, with Roche’s PD-L1 checkpoint inhibitor, atezolizumab, for the first-line treatment of NSCLC. [Galecto, Inc.] |
|
|
|
|
| December 8 – 10, 2022 Los Angeles, California, United States |
|
|
|
|
|
| Washington University School of Medicine – St. Louis, Missouri, United States |
|
|
|
| University of Vermont – Burlington, Vermont, United States |
|
|
|
| University of Pittsburgh School of Medicine – Pittsburgh, Pennsylvania, United States |
|
|
|
| Temple University – Philadelphia, Pennsylvania, United States |
|
|
|
| German Cancer Research Center in the Helmholtz Association – Heidelberg, Germany |
|
|
|
|